Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

NCT06916520 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Coronary Arterial Disease (CAD)
Percutaneous Coronary Intervention (PCI)

Interventions

DRUG: Prasugrel 5 mg
DRUG: Dual Antiplatelet (DAPT) Therapy

Sponsor

J.P.S Henriques